BELINDA GARZA: Open Payments
NPI 1659617827 · DONNA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,913 in 129 payments from 15 companies in 2025. Trend: 2023 $2,094 · 2024 $2,777 · 2025 $2,913
Food & beverage: $2,714Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $1,026 |
| Amgen Inc. | 32 | $494 |
| UCB, Inc. | 20 | $378 |
| ABBVIE INC. | 19 | $267 |
| AstraZeneca Pharmaceuticals LP | 5 | $206 |
| Novartis Pharmaceuticals Corporation | 6 | $113 |
| Janssen Scientific Affairs, LLC | 1 | $98 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Lilly USA, LLC | 2 | $52 |
| PFIZER INC. | 3 | $43 |
Products named: TREMFYA, Bimzelx, ENBREL, SAPHNELO, RINVOQ, COSENTYX, BENLYSTA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
